Published in Telemedicine Business Week, August 25th, 2004
Sales for the fiscal year ended June 30, 2004, were $258.8 million, an increase of 20%, compared with the $214.9 million reported for the last fiscal year. Excluding the favorable effects of currency fluctuations, sales grew by 12% for the year. Diluted earnings per share for the year were $1.89, an increase of 30% over the $1.45 reported last year. Diluted earnings per share for the year increased 24% compared with the $1.52 reported for fiscal 2003, excluding the write-off of an investment in an unaffiliated entity in fiscal 2003. Cash flow from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week